Biogen

Anonymous board for Biogen
Post thread
Leaving MS, hopefully.
Replies
0
Views
1K
anonymous
What’s happening?
Replies
8
Views
4K
anonymous
Medicare maintains limits on Eisai’s new Alzheimer’s drug | BioPharma Dive
Replies
2
Views
833
anonymous
Biogen CEO says company 'lost its way,' cuts $125M MS partnership amid declining revenue – Endpoints
Replies
5
Views
3K
anonymous
FDA adds warning of 'larger areas of bleeding' in brain to Biogen's Aduhelm label – Endpoints News
Replies
5
Views
1K
anonymous
Bring on the Biogen lies
Replies
31
Views
9K
anonymous
Axios: Health experts want FDA safety review of fast-tracked Alzheimer's drug
Replies
2
Views
980
anonymous
Scratching head. I have read the data - this is different from Adu how?
Replies
12
Views
2K
anonymous
Approval For Anavex's (AVXL) Blarcamesine Looks Inevitable | Seeking Alpha
Replies
0
Views
970
anonymous
Axios: New Alzheimer's drug may have limited real-world impact for patients
Replies
4
Views
949
anonymous
NatGeo: Is a new drug to treat Alzheimer‘s safe?
Replies
1
Views
686
anonymous
Opinion | How the FDA got too cozy with Alzheimer's drugmaker Biogen - The Washington Post
Replies
1
Views
1K
anonymous
JPM23, Day 1: Humana not expecting high uptake of lecanemab
Replies
3
Views
1K
anonymous
Approved
Replies
8
Views
2K
anonymous
The Free Press: The Reason There’s Been No Cure for Alzheimer’s
Replies
1
Views
773
anonymous
FierceBiotech: 3rd patient death tied to Eisai's Alzheimer's drug reported
Replies
12
Views
2K
anonymous
Congressional report: U.S. FDA broke own protocols in approving Biogen Alzheimer's drug
Replies
5
Views
1K
anonymous
8 takeaways from investigation of Alzheimer’s drug approval - STAT
Replies
2
Views
1K
anonymous
Will this ever end?
Replies
6
Views
2K
anonymous
Will the FDA approve a very dangerous therapy?
Replies
15
Views
1K
anonymous
Top Bottom
Back
Post thread